-
EP1389128
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP1389128
| EP1389128 - METHOD FOR INHIBITING ATHEROSCLEROTIC PLAQUE FORMATION [Right-click to bookmark this link] | Status | The application has been withdrawn Status updated on 13.05.2005 Database last updated on 03.09.2024 | Most recent event Tooltip | 13.05.2005 | Withdrawal of application | published on 29.06.2005 [2005/26] | Applicant(s) | For all designated states LUDWIG INSTITUTE FOR CANCER RESEARCH 605 Third Avenue New York New York 10158 / US | For all designated states LEIDEN UNIVERSITY P.O. Box 8506 2300 RA Leiden / NL | [N/P] |
| Former [2004/08] | For all designated states LUDWIG INSTITUTE FOR CANCER RESEARCH 605 Third Avenue New York, New York 10158 / US | ||
| For all designated states Leiden University P.O. Box 8506 2300 RA Leiden / NL | Inventor(s) | 01 /
VAN SNICK, Jacques Avenue Hippocrate 74 UCL B-1200 Brussels / BE | 02 /
KUIPER, Johan Krugerlaan 37 NL-2806 EB Gouda / NL | 03 /
VON DER THUSEN, Jan, Hinrich Zonnebloemstraat 27 NL-2014 VV Haarlem / NL | 04 /
BIESSEN, Ericus, Anna, Leonardus Marga Klompestraat 40 NL-2331 RX Leiden / NL | 05 /
VAN BERKEL, Theodorus, Josephus, Cornelis Van Nesstraat 44 NL-2024 DP Haarlem / NL | [2004/08] | Representative(s) | Brasnett, Adrian Hugh, et al Mewburn Ellis LLP City Tower 40 Basinghall Street London EC2V 5DE / GB | [N/P] |
| Former [2004/08] | Brasnett, Adrian Hugh, et al Mewburn Ellis York House 23 Kingsway London WC2B 6HP / GB | Application number, filing date | 02725707.0 | 17.04.2002 | [2004/08] | WO2002US12057 | Priority number, date | US20010283934P | 17.04.2001 Original published format: US 283934 P | US20010284232P | 18.04.2001 Original published format: US 284232 P | [2004/08] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | WO02083076 | Date: | 24.10.2002 | Language: | EN | [2002/43] | Type: | A2 Application without search report | No.: | EP1389128 | Date: | 18.02.2004 | Language: | EN | The application published by WIPO in one of the EPO official languages on 24.10.2002 takes the place of the publication of the European patent application. | [2004/08] | Search report(s) | International search report - published on: | US | 08.05.2003 | (Supplementary) European search report - dispatched on: | EP | 05.04.2005 | Classification | IPC: | A61K38/20, A61K47/48, A61P9/10 | [2005/25] | CPC: |
A61K38/206 (EP,US);
A61K47/60 (EP,US);
A61P9/10 (EP)
|
| Former IPC [2005/23] | A61K38/20, H04L1/00, A61K47/48, A61P9/10 | ||
| Former IPC [2005/20] | A61K38/20, A61K47/48, H04L1/00, A61P9/10 | ||
| Former IPC [2004/08] | A61K38/16, A61K38/17, A61K38/18, A61K38/19, A61K38/20 | Designated contracting states | AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE, TR [2004/08] | Extension states | AL | Not yet paid | LT | Not yet paid | LV | Not yet paid | MK | Not yet paid | RO | Not yet paid | SI | Not yet paid | Title | German: | VERFAHREN ZUR HEMMUNG ATHEROSKLEROTISCHER PLAQUEBILDUNG | [2004/08] | English: | METHOD FOR INHIBITING ATHEROSCLEROTIC PLAQUE FORMATION | [2004/08] | French: | PROCEDE D'INHIBITION DE LA FORMATION DE PLAQUE D'ATHEROSCLEROSE | [2004/08] | Entry into regional phase | 14.11.2003 | National basic fee paid | 14.11.2003 | Search fee paid | 14.11.2003 | Designation fee(s) paid | 14.11.2003 | Examination fee paid | Examination procedure | 14.11.2002 | Request for preliminary examination filed International Preliminary Examining Authority: US | 14.11.2003 | Amendment by applicant (claims and/or description) | 14.11.2003 | Examination requested [2004/08] | 28.04.2005 | Application withdrawn by applicant [2005/26] | Fees paid | Renewal fee | 23.04.2004 | Renewal fee patent year 03 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [PX] - KUIPER JOHAN ET AL, "Interleukin 9 treatment of LDL receptor deficient mice inhibits atherosclerotic plaque formation", CIRCULATION, & SCIENTIFIC SESSIONS 2001 OF THE AMERICAN HEART ASSOCIATION; ANAHEIM, CALIFORNIA, USA; NOVEMBER 11-14, 2001, (20011023), vol. 104, no. 17 Supplement, ISSN 0009-7322, page II.320, XP009039967 [PX] 1-15 * the whole document * | International search | [A] - WICKENHAUSER ET AL., "Secretion of cytokines (interleukins-1 alpha, -3, and -6 and granulocyte-macrophage colony-stimulating factor) by normal human bone marrow megakaryocytes", BLOOD, vol. 85, no. 3, pages 685 - 691, XP002961927 | [A] - YANG ET AL., "Expression cloning of a cDNA encoding a novel human hematopoietic growth factor: human homologue of murine T-cell growth factor P40", BLOOD, (19891101), vol. 74, no. 6, pages 1880 - 1884, XP000603654 |